Cyclodinone drops, 50 ml

Menstrual irregularities, premenstrual syndrome, mastodynia.

CyclodinoneЃ oral drops are taken orally 40 drops 1 time a day in the morning with a little water. The duration of treatment is at least 3 months (without interruption during menstruation). After the symptoms disappear and the condition improves, treatment should be continued for several weeks after consulting a doctor. If the symptoms of the disease persist against the background of the use of the drug, you should consult a doctor. If, after the completion of treatment, complaints reappear, it is necessary to consult a doctor.

Active ingredient:

Common barnacle * fruit dry extract

(7-11: 1, extractant - ethanol 70% v / v) - 0.240 g

Excipients: povidone K 30, sorbitol 70% (non-crystallizing), polysorbate 20, sodium saccharinate, peppermint flavoring, ethanol 96%, purified water.

* - Latin name - Vitex agnus-castus L.

Individual hypersensitivity to the components of the drug, breast cancer, pituitary tumors, age up to 18 years (there are no data on the effectiveness and safety of the drug in this age group), fructose malabsorption (due to the sorbitol content in the drug), pregnancy and breastfeeding.

Dosage form

Oral drops

Manufacturer

Bionorica SE, Kerschensteinerstrasse 11-15, 92318, Neumarkt, Germany

Composition (per 100 g drops):

Active ingredient:

Common barnacle * fruit dry extract

(7-11: 1, extractant - ethanol 70% v / v) - 0.240 g

Excipients: povidone K 30, sorbitol 70% (non-crystallizing), polysorbate 20, sodium saccharinate, peppermint flavoring, ethanol 96%, purified water.

* - Latin name - Vitex agnus-castus L.

Description

Transparent, yellow-brown liquid with a characteristic odor. Slight sediment may precipitate during storage.

Pharmacotherapeutic group

Preparations for the treatment of gynecological diseases

Pharmacological properties

The components of the drug have a normalizing effect on the concentration of sex hormones.

The main active ingredient of the drug is common twig. The dopaminergic effects of the drug, causing a decrease in prolactin production, eliminate hyperprolactinemia. An increased concentration of prolactin disrupts the secretion of gonadotropins, as a result of which there may be disturbances in follicular maturation, ovulation and the formation of a corpus luteum, which further leads to an imbalance between estradiol and progesterone and can cause menstrual irregularities, as well as mastodynia. Unlike estrogens and other hormones, prolactin also has a direct stimulating effect on the proliferative processes in the mammary glands, enhancing the formation of connective tissue and causing the expansion of the milk ducts. A decrease in the concentration of prolactin leads to the reverse development of pathological processes in the mammary glands and relieves pain.Rhythmic production and normalization of the ratio of gonadotropic hormones leads to the normalization of the second phase of the menstrual cycle.

Indications for use

Menstrual irregularities, premenstrual syndrome, mastodynia.

Contraindications

Individual hypersensitivity to the components of the drug, breast cancer, pituitary tumors, age up to 18 years (there are no data on the effectiveness and safety of the drug in this age group), fructose malabsorption (due to the sorbitol content in the drug), pregnancy and breastfeeding.

Carefully

Liver disease, epilepsy, history of estrogen-dependent malignant neoplasms in patients. Before using the drug, you should consult your doctor.

Application during pregnancy and lactation

The drug is not used during pregnancy and during breastfeeding.

With an increase in the regularity of the menstrual cycle while taking the drug, the likelihood of pregnancy increases. When pregnancy occurs, the drug should be discontinued.

Method of administration and dosage

CyclodinoneЃ oral drops are taken orally 40 drops 1 time a day in the morning with a little water. The duration of treatment is at least 3 months (without interruption during menstruation). After the symptoms disappear and the condition improves, treatment should be continued for several weeks after consulting a doctor. If the symptoms of the disease persist against the background of the use of the drug, you should consult a doctor. If, after the completion of treatment, complaints reappear, it is necessary to consult a doctor.

Side effects

Possible allergic reactions to the components of the drug (skin rash, urticaria, angioedema, shortness of breath, dysphagia), gastrointestinal disorders (pain in the epigastric region, nausea), headache, dizziness, acne, menstrual irregularities. The frequency of adverse reactions is not known, i.e. cannot be estimated based on available data. If the above-described adverse reactions or other adverse reactions not listed in the Instructions appear, you should stop taking the drug and consult a doctor.

Overdose

In case of overdose, it is possible to increase the severity of dose-dependent side effects. Treatment is symptomatic.

Interaction with other medicinal products

A mutual decrease in effectiveness is possible while taking dopamine receptor antagonists, as well as interaction with dopamine receptor agonists, estrogens and antiestrogens. When taking these medications, you should consult your doctor before you start taking CyclodinoneЃ. Interaction with other drugs is still unknown.

special instructions

In case of pain in the mammary glands and / or weakness, depression, as well as in case of menstrual irregularities, when taking the drug, it is necessary to consult a doctor, since it may be a question of diseases requiring medical advice.

Before using the drug, you should consult your doctor.

In order to monitor the effectiveness of the treatment, a monthly consultation with a doctor is recommended.

The preparation contains 17.0 - 19.0% ethanol (in volume ratio). Drops for oral administration should not be used in patients suffering from alcoholism, as well as after successful anti-alcohol treatment.

The bottle should be kept upright during use.

During storage of a medicinal product, a slight precipitate may form, which does not affect its effectiveness.

Shake well before use!

Influence on the ability to drive vehicles, mechanisms

When used in recommended doses, the drug does not affect the ability to perform potentially hazardous activities that require an increased concentration of attention and speed of psychomotor reactions (driving, working with moving mechanisms, the work of a dispatcher and an operator).

Release form

Oral drops. 50 or 100 ml in a dark glass bottle with a dosing drip device on top, with a screw cap and a safety ring. Each bottle is placed in a cardboard box along with instructions for use.

Storage conditions

Store in its original packaging at a temperature not exceeding 25 ? C.

Keep out of the reach of children!

Shelf life

3 years.

Do not use after the expiration date.

Conditions of dispensing from pharmacies

Available without a prescription.